Alopecia and platelet-derived therapies

Stem Cell Investigation

Volumn 4, Issue 11, 2017, Pages

  Cole, John P ^a   Cole, Megan A ^a   Insalaco, Chiara ^b,c   Cervelli, Valerio ^b   Gentile, Pietro ^b,d  

^a Cole Hair Transplant Group ^*  (United States)

^b Plastic and Reconstructive Surgery Department   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d CATHOLIC UNIVERSITY OUR LADY OF GOOD COUNSEL   (Albania)

Author keywords

Androgenetic alopecia (AGA); Concentrations; Platelet rich plasma (PRP)

Indexed keywords

HEMATOLOGIC AGENT; PLATELET DERIVED GROWTH FACTOR BB; PLATELET LYSATE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACTIVATED THROMBOCYTE RICH PLASMA; ADULT; ARTICLE; BLOOD CELL THERAPY; CASE REPORT; CELL THERAPY; CELL WALL; CENTRIFUGATION; CLINICAL ARTICLE; DUAL ANTIPLATELET THERAPY; FOLLICULAR GRAFT; FOLLOW UP; HAIR FOLLICLE; HAIR GROWTH; HAIR LOSS; HUMAN; MALE; MALE TYPE ALOPECIA; MIDDLE AGED; SKIN GRAFT; SURFACE AREA; SURVIVAL RATE; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA; ULTRASOUND;

EID: 85042234326     PISSN: None     EISSN: 23069759     Source Type: Journal    
DOI: 10.21037/sci.2017.11.01     Document Type: Article

References (26)

1. Ellis JA, Sinclair R, Harrap SB. Androgenetic alopecia: pathogenesis and potential for therapy. Expert Rev Mol Med 2002;4:1-11.
2. Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol 2008;59:547-66; quiz 567-8.
3. Rousso DE, Kim SW. A review of medical and surgical treatment options for androgenetic alopecia. JAMA Facial Plast Surg 2014;16:444-50.
4. Schweiger ES, Boychenko O, Bernstein RM. Update on the pathogenesis, genetics and medical treatment of patterned hair loss. J Drugs Dermatol 2010;9:1412-9.
5. Olsen EA, Weiner MS. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment. J Am Acad Dermatol 1987;17:97-101.
6. Gupta AK, Carviel JL. Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia. J Dermatolog Treat 2017;28:55-8.
7. Gentile P, Cole JP, Cole MA, et al. Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems. Int J Mol Sci 2017;18. pii: E408.
8. Takikawa M, Nakamura S, Nakamura S, et al. Enhanced effect of platelet-rich plasma containing a new carrier on hair growth. Dermatol Surg 2011;37:1721-9.
9. Gentile P, Garcovich S, Bielli A, et al. The Effect of Platelet-Rich Plasma in Hair Regrowth: A Randomized Placebo-Controlled Trial. Stem Cells Transl Med 2015;4:1317-23.
10. Gkini MA, Kouskoukis AE, Tripsianis G, et al. Study of platelet-rich plasma injections in the treatment of androgenetic alopecia through an one-year period. J Cutan Aesthet Surg 2014;7:213-9.
11. Cervelli V, Garcovich S, Bielli A, et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int 2014;2014:760709.
12. Bouhanna P, Bouhanna E. Hair Transplantation for Aesthetic Surgery of the Scalp and Body Hair. In: Bouhanna P, Bouhanna E, editors. Alopecias: Diagnosis and Treatments. Boca Raton: CRC Press-Taylor & Francis Group, 2016:163-88.
13. Cole JP. Status of Individual Follicular Group Harvesting. Hair Transplant Forum Int 2009;19:20.
14. Jimenez F, Izeta A, Poblet E. Morphometric analysis of the human scalp hair follicle: practical implications for the hair transplant surgeon and hair regeneration studies. Dermatol Surg 2011;37:58-64.
15. Zhang H, Tasnim F, Ying JY, et al. The impact of extracellular matrix coatings on the performance of human renal cells applied in bioartificial kidneys. Biomaterials 2009;30:2899-911.
16. Rose PT. Hair restoration surgery: challenges and solutions. Clin Cosmet Investig Dermatol 2015;8:361-70.
17. Uebel CO, da Silva JB, Cantarelli D, et al. The role of platelet plasma growth factors in male pattern baldness surgery. Plast Reconstr Surg 2006;118:1458-66; discussion 1467.
18. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105 Suppl 1:S13-33.
19. Pierce GF, Mustoe TA, Lingelbach J, et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 1989;109:429-40.
20. Shipley GD, Pittelkow MR, Wille JJ Jr, et al. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res 1986;46:2068-71.
21. Lichtenberger BM, Mastrogiannaki M, Watt FM. Epidermal β-catenin activation remodels the dermis via paracrine signalling to distinct fibroblast lineages. Nat Commun 2016;7:10537.
22. Andl T, Reddy ST, Gaddapara T, et al. WNT signals are required for the initiation of hair follicle development. Dev Cell 2002;2:643-53.
23. Li ZJ, Choi HI, Choi DK, et al. Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth. Dermatol Surg 2012;38:1040-6.
24. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978;253:2769-76.
25. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
26. Assoian RK, Komoriya A, Meyers CA, et al. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983;258:7155-60.